Related Experiment Videos
Second malignancies in children: the usual suspects?
J Moppett1, A Oakhill, A W Duncan
1Department of Paediatric Oncology, Bristol Royal Hospital for Sick Children, St. Michael's Hill, BS2 8BJ, Bristol, UK.
European Journal of Radiology
|June 12, 2001
Summary
This review details second malignant neoplasms (SMNs) after childhood cancer treatment, covering incidence, genetic factors, and treatment influences. It highlights key primary and secondary cancers, emphasizing risk identification and radiological diagnosis.
Area of Science:
- Oncology
- Genetics
- Pediatrics
Context:
- Childhood cancer survivors face increased risks of developing secondary malignant neoplasms (SMNs).
- Understanding the long-term effects of cancer treatment is crucial for improving patient outcomes.
- Genetic predisposition plays a significant role in SMN development.
Purpose:
- To provide an updated review of SMNs following childhood cancer treatment.
- To discuss the incidence, genetic factors, and treatment-related influences on SMNs.
- To highlight key primary and secondary malignancies, diagnostic methods, and risk factors.
Summary:
- This article reviews SMNs in childhood cancer survivors, examining incidence, genetic predispositions, and the impact of primary cancer type and treatment (chemotherapy, radiotherapy).
- It focuses on specific associations, including Hodgkin's disease, retinoblastoma, and acute lymphoblastic leukemia, and highlights common SMNs such as CNS tumors, osteosarcoma, and melanoma.
- Emphasis is placed on identifying high-risk patients and utilizing radiological features for diagnosis and screening, supported by case histories.
Impact:
- Informs clinicians about the risks and patterns of SMNs in childhood cancer survivors.
- Aids in the development of targeted screening protocols for high-risk individuals.
- Contributes to personalized survivorship care by considering genetic and treatment factors.